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Dear Editor,
Chikungunya fever is an acute disease caused by an alphavirus from 
the Togaviridae family and transmitted by Aedes species mosquitoes, 
mainly Aedes aegypti. It is recognized as an acute disease characterized 
by fever, arthralgia, arthritis, and rash, and multiple complications 
during the chronic phase have been described1. These complications 
may manifest in a variety of organs and systems, including the 
skin, eyes, and neurological, genitourinary, and cardiac systems2,3. 
The complete range of chikungunya-induced manifestations is not 
completely known. 
Among psychiatric disorders, an increase in mood disorders, 
such as depression, has been experienced by some patients during 
the chronic phase of chikungunya4. It is believed that inflammatory 
biomarkers affecting the central nervous system may be involved 
in this process. An increase in the levels of interleukin-6 (IL-6) and 
other cytokines during the acute phase of chikungunya can be related 
to depression. The fact that IL-6 level remains elevated during the 
chronic phase is associated with chronic pain, leading to behaviors 
that may be responsible for the increased risk of mood disorders5. 
The potential of chikungunya fever to cause psychiatric disorders 
warrants investigation of an organic etiology in cases of mental illness.
Studies have shown that chikungunya virus infection exacerbates 
prior comorbidities, and conditions such as chronic kidney and 
autoimmune disease may be exacerbated during the acute phase6,7. 
However, no large-scale studies have investigated the relationship 
between the presence of previous psychiatric conditions and their 
exacerbation by chikungunya virus infection. Some case reports 
have suggested that decompensation of prior psychiatric disorders 
such as bipolar disorder8 occurs, but this relationship remains poorly 
understood.
Currently, the best evidence is from a 34-patient Indian study 
by Bhatia et al.4, in which patients manifested a myriad of mental 
illnesses such as anxiety, depression, sleep disorder, panic disorder, 
somatoform disorder, and neurasthenia. Studies regarding other 
arboviruses such Zika virus and Dengue virus are scarce, although 
they do not represent diseases with a chronic component as with 
chikungunya9. 
Chikungunya fever has been a public health problem in Latin 
America since the first registered cases in 2013, followed by a 
2016-2017 outbreak with more than 200,000 confirmed cases 
in Brazil10. Since then, cases have been reported annually in the 
Latin American region, including Brazil. In Brazil, the virus still 
remains in circulation, which creates an opportunity for new 
research and understanding of the disease, as well as its relationship 
with psychiatric disorders. A possible study design would involve 
retrospective studies to analyze patients’ medical records for the acute 
phase and follow-up of symptomatic patients with chronic disease, 
while seeking to understand the mental health sequelae. 
The need for new research is urgent. To our knowledge, little 
information has been published on the relationship between 
chikungunya disease and mental illness in the last 5 years, and 
chikungunya-related mental illness disorders need to be understood. 
More studies are necessary to understand the pathophysiological 
mechanisms, risk factors, epidemiologic characteristics, clinical 
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